Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization

Cancer Discovery(2025)10.1158/2159-8290.cd-25-0377Source: DataRank Database

Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization is a research paper published in Cancer Discovery (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)Impact (FWCI 0.65)OA: hybridTopics (45)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Padma Kadiyala ORCID,Jake McGue ORCID,Lei Sun ORCID,Aadith Kumar ORCID,Carlos E. Espinoza ORCID

Live enrichment

PubMed:40905825 OpenAlex:https://openalex.org/W4413985794

National Institutes of Health

Grant: R01CA268426

National Institutes of Health

Grant: U01CA224145

National Institutes of Health

Grant: R01CA260752

National Institutes of Health

Grant: R01CA271510

National Institutes of Health

Grant: R01CA264843

National Institutes of Health

Grant: U01CA274154

National Institutes of Health

Grant: T32CA00967

National Institutes of Health

Grant: R01DK128102

U.S. Department of Veterans Affairs

Grant: I01BX005777

BLRD VA

Grant: IK2 BX005875

NCI NIH HHS

Grant: P30 CA046592

NCI NIH HHS

Grant: T32 CA009676

NCI NIH HHS

Grant: R01 CA290780

Society of University Surgeons (SUS)

Frederick A. Coller Surgical Society (Coller Surgical Society)

FWCI

0.65

Citation Percentile

0.7%

Citation Trend

2025

hybridLicense: cc-by-nc-nd

journalhttps://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.CD-25-0377/3646844/cd-25-0377.pdf

publisherhttps://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.CD-25-0377/3646844/cd-25-0377.pdf

publisherhttps://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.CD-25-0377/3665544/cd-25-0377.pdf

publisherhttps://aacrjournals.org/cancerdiscovery/article-pdf/16/1/114/3722550/cd-25-0377.pdf

journalhttps://doi.org/10.1158/2159-8290.cd-25-0377

Fields of Study

Toxic Organic Pollutants ImpactCarcinogens and Genotoxicity AssessmentSmoking Behavior and CessationReceptors, Aryl HydrocarbonAnimalsPancreatic NeoplasmsHumansMiceLigandsDisease ProgressionCarcinoma, Pancreatic DuctalDisease Models, AnimalInterleukin-22FemaleInterleukins

MeSH Terms

Interleukin-22AnimalsDisease Models, AnimalFemaleHumansInterleukinsLigandsPancreatic NeoplasmsReceptors, Aryl HydrocarbonDisease ProgressionCarcinoma, Pancreatic DuctalMice

Keywords

Aryl hydrocarbon receptorCancer researchCarcinogenesisPancreatic cancerTumor progressionCarcinogenImmune systemCD8PancreasReceptorMedicineBiologyCancerInternal medicineImmunologyTranscription factorGeneBiochemistry